Form 4: GlycoMimetics Director Acquires Shares in Lieu of Fees

Director Daniel M. Junius acquired 5,209 shares of GlycoMimetics Inc. common stock on March 29, 2024, in lieu of board and committee retainer fees.

Summary

• On March 29, 2024, Daniel M. Junius, a director of GlycoMimetics Inc., acquired 5,209 shares of common stock.
• The acquisition was made in lieu of $15,625 in board and committee retainer fees, according to the issuer's non-employee director compensation policy.
• The price of the acquired shares was $3.
• Following the transaction, Junius directly owns 98,459 shares of GlycoMimetics Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction, but the director taking shares instead of cash could be seen as a slightly positive signal.

Positives

• The director's decision to take shares in lieu of cash compensation demonstrates confidence in the company's future.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Directors often receive equity as part of their compensation.

Related Party Transactions

• The acquisition of shares by the director in lieu of fees constitutes a related party transaction.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It could be perceived as a positive signal by shareholders if they view it as the director's confidence in the company.

Key Dates